Literature DB >> 15612642

New predictors for several ADME/Tox properties: aqueous solubility, human oral absorption, and Ames genotoxicity using topological descriptors.

Joseph R Votano1, Marc Parham, Lowell H Hall, Lemont B Kier.   

Abstract

In silico predictive models for aqueous solubility, human intestinal absorption (HIA), and Ames genotoxicity were developed principally using artificial neural net (ANN) analysis and topological descriptors. Approximately 10,000 compounds spread across three data sets were used in the construction of these quantitative-structure-activity/property-relationship (QSAR/QSPR) models. For aqueous solubility, 5,037 chemically diverse compounds were used to construct ANN-QSPRs for intrinsic aqueous solubility. When these robust models were applied to 938 compounds in external validation, they gave an r2 = 0.78 with 84% predicted within 1 log unit for these new chemical entities (NCEs). 417 therapeutic drugs were used in the development of an ANN-QSPR to predict for percent oral absorption (%OA). For validation testing on 195 new drugs, 92% of the compounds were predicted to within 25% of their reported %OA values, which ranged from 0% to 100%. Polar surface area and logP, the octanol-water partition coefficient, were found to be important descriptors in our QSPR model. Development of an ANN-QSAR as a genotoxicity predictor for S. typhimurium employed 2963 compounds including 290 therapeutic drugs. Validation results on 400 NCEs with the ANN-QSAR gave a concordance of 83% which rose to 91% when a confidence indicator was applied. With new drugs a concordance of 92% was reached, which increased to 97% when the reliably indicator was invoked.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15612642     DOI: 10.1023/b:modi.0000047512.82293.75

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  9 in total

1.  On an aspect of calculated molecular descriptors in QSAR studies of quinolone antibacterials.

Authors:  Payel Ghosh; Megha Thanadath; Manish C Bagchi
Journal:  Mol Divers       Date:  2006-08-02       Impact factor: 2.943

2.  Reverse fingerprinting, similarity searching by group fusion and fingerprint bit importance.

Authors:  Chris Williams
Journal:  Mol Divers       Date:  2006-09-21       Impact factor: 2.943

3.  CE50: quantifying collision induced dissociation energy for small molecule characterization and identification.

Authors:  Tzipporah M Kertesz; Lowell H Hall; Dennis W Hill; David F Grant
Journal:  J Am Soc Mass Spectrom       Date:  2009-06-21       Impact factor: 3.109

Review 4.  In vitro to in vivo extrapolation for high throughput prioritization and decision making.

Authors:  Shannon M Bell; Xiaoqing Chang; John F Wambaugh; David G Allen; Mike Bartels; Kim L R Brouwer; Warren M Casey; Neepa Choksi; Stephen S Ferguson; Grazyna Fraczkiewicz; Annie M Jarabek; Alice Ke; Annie Lumen; Scott G Lynn; Alicia Paini; Paul S Price; Caroline Ring; Ted W Simon; Nisha S Sipes; Catherine S Sprankle; Judy Strickland; John Troutman; Barbara A Wetmore; Nicole C Kleinstreuer
Journal:  Toxicol In Vitro       Date:  2017-12-05       Impact factor: 3.500

5.  Antiplasmodial activity of [(aryl)arylsulfanylmethyl]Pyridine.

Authors:  Sanjay Kumar; Sajal Kumar Das; Sumanta Dey; Pallab Maity; Mithu Guha; Vinay Choubey; Gautam Panda; Uday Bandyopadhyay
Journal:  Antimicrob Agents Chemother       Date:  2007-11-19       Impact factor: 5.191

6.  MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist.

Authors:  Heather N Richardson; Yu Zhao; Eva M Fekete; Cindy K Funk; Peter Wirsching; Kim D Janda; Eric P Zorrilla; George F Koob
Journal:  Pharmacol Biochem Behav       Date:  2007-10-23       Impact factor: 3.533

7.  Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses.

Authors:  Curran Landry; Marlene T Kim; Naomi L Kruhlak; Kevin P Cross; Roustem Saiakhov; Suman Chakravarti; Lidiya Stavitskaya
Journal:  Regul Toxicol Pharmacol       Date:  2019-10-03       Impact factor: 3.271

8.  Anti-prion activity of a panel of aromatic chemical compounds: in vitro and in silico approaches.

Authors:  Natalia C Ferreira; Icaro A Marques; Wesley A Conceição; Bruno Macedo; Clarice S Machado; Alessandra Mascarello; Louise Domeneghini Chiaradia-Delatorre; Rosendo Augusto Yunes; Ricardo José Nunes; Andrew G Hughson; Lynne D Raymond; Pedro G Pascutti; Byron Caughey; Yraima Cordeiro
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

9.  Structure-activity models of oral clearance, cytotoxicity, and LD50: a screen for promising anticancer compounds.

Authors:  John C Boik; Robert A Newman
Journal:  BMC Pharmacol       Date:  2008-06-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.